Collapsing the Tumor-Supportive Immune Portfolio of Breast Cancer to Achieve Durable Reduction of Metastasis

Grant

Date/time Interval

  • September 1, 2019 - August 31, 2022
  • Total Award Amount

  • 742499.00
  • Direct Costs

  • 500000.00
  • Sponsor Award Id

  • W81XWH1910755
  • Contributor

  • Dongquan Chen M.D., Ph.D.   Investigator  
  • Lalita Samant   Principal Investigator  
  • Rajeev Samant Ph.D.   Investigator  
  • Robert Welner Ph.D.   Investigator  
  • Tika Benveniste Ph.D.   Investigator